These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 7526756

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment with immunomodulating drugs of patients with operated cancer. Long-term results].
    Sortini A, Di Marco L, Navarra G, Donini A, Fiorentini G, Santini M, Sartori A, Donini I.
    Minerva Chir; 1994 Nov; 49(11):1101-5. PubMed ID: 7708231
    [Abstract] [Full Text] [Related]

  • 3. [The possibility of the restoration of interferon formation by biologically active thymus factors in experimentally induced immunodepression].
    Chernenko OD, Grinevich IuA.
    Vopr Virusol; 1991 Nov; 36(4):309-10. PubMed ID: 1724585
    [Abstract] [Full Text] [Related]

  • 4. Immunostimulation and host resistance against infection: therapeutic perspectives.
    Fauve RM.
    Adv Nephrol Necker Hosp; 1980 Nov; 9():167-86. PubMed ID: 6157316
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Immunostimulants].
    Lesavre P, Bach JF.
    Rev Prat; 1980 Mar 11; 30(15):907-8, 911-5. PubMed ID: 6154961
    [No Abstract] [Full Text] [Related]

  • 7. [Immunotherapy of sepsis: myth or reality?].
    Vinnitskiĭ LI, Vitvitskaia IM, Popov OIu.
    Anesteziol Reanimatol; 1997 Mar 11; (3):89-97. PubMed ID: 9290000
    [No Abstract] [Full Text] [Related]

  • 8. [Characteristics and clinical use of immunostimulants].
    Shirinskiĭ VS, Zhuk EA.
    Ter Arkh; 1990 Mar 11; 62(12):125-32. PubMed ID: 1707558
    [No Abstract] [Full Text] [Related]

  • 9. [New therapeutic possibilities in acute and chronic viral hepatitis].
    Kiczka W.
    Przegl Epidemiol; 1979 Mar 11; 33(2):217-25. PubMed ID: 482640
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Thymostimulin effect on the immune response in neoplastic patients submitted to surgical treatment.
    Cangemi V, Volpino P, D'Andrea N, Gentili S, Fabrizi S, Ippoliti F, Piat G.
    Panminerva Med; 1993 Dec 11; 35(4):218-23. PubMed ID: 8202335
    [Abstract] [Full Text] [Related]

  • 12. [Immunostimulants and infectious diseases].
    Grob PJ, Fontana A.
    Ther Umsch; 1982 Sep 11; 39(9):668-74. PubMed ID: 6184840
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Thymostimulin effect on the immune response in pulmonary carcinoma with or without surgical treatment.
    Cangemi V, Volpino P, D'Andrea N, Gentili S, Salsano F, Rivi R, Ippoliti F, Piat G.
    Panminerva Med; 1993 Dec 11; 35(4):224-30. PubMed ID: 8202336
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Therapeutic immunopharmacology.
    Hadden JW.
    Curr Opin Immunol; 1989 Dec 11; 2(2):258-63. PubMed ID: 2483056
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Development of a new approach to the pathogenetic therapy of oncological patients].
    Mkrtchian LN, Shukurian SG, Kamalian LA, Aleksanian KA, Ambartsumian AM.
    Eksp Onkol; 1990 Dec 11; 12(1):13-5. PubMed ID: 1688762
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.